Latest Articles

Per- and polyfluoroalkyl substances (PFAS) are widely used and persist in the environment and the human body for extended periods. Technology Networks invited Dr. Carol Kwiatkowski to an Ask Me Anything session to answer your questions about PFAS and their impact on human health.

A diverse array of biological medicines are now used to prevent and treat a wide range of illnesses. This article will discuss the development of cell lines in biopharma and will touch on key considerations, such as future manufacturability.

Antimicrobial resistance (AMR) is threatening the effective treatment and prevention of a wide range of infections, with serious potential consequences for health and the economy. We spoke to Dr. Alaa Riezk, research associate at the Centre for Antimicrobial Optimisation (CAMO), Imperial College London, about the problem of usage and dosage of antimicrobials and AMR and how he and the team are working to address it.

Martin Farley, sustainable research adviser at UCL and director of Green Lab Associates, was invited to Technology Networks’ Ask Me Anything session to answer your questions about the future of sustainability in research and laboratory practices.

In this opinion piece, Neil Ward explores how advances in sequencing could help to provide new insights for rare disease patients.

Host cell proteins can prove problematic for the development of novel biopharmaceuticals. This article will highlight some of the latest advances in host cell analysis strategies and how they are being implemented.

Spider silk is a remarkable material, offering high tensile strength and natural elasticity. In this article, learn how a group of scientists are currently exploring its untapped potential in medical and materials science.

This article focuses on the use of high-throughput screening approaches in drug discovery and discusses the latest developments in this area.

Insight into the history of human–pathogen interactions, how different societies responded to disease and the origin of pathogens supports our understanding of human health and evolution. We explore what we're still learning about ancient pathogens and diseases.

This article explores the importance of early risk prediction in preventing cardiovascular disease (CVD), the role of biomarkers in this prediction and nutritional habits to reduce the risk of CVD.